Published online before print October 6, 2005, doi: 10.1161/01.STR.0000185696.73938.e0
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:2421.)
© 2005 American Heart Association, Inc.
Original Contributions |
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (
80 Years) Stroke Patients
From the Neurologische Klinik (J.B.), Kreiskrankenhaus Altenburg, Altenburg, Germany; Neurologische Klinik (J.R., J.G.), Klinikum Minden, University Hannover, Minden, Germany; Neuroradiologische Abteilung (T.K., J.F.), Klinik und Poliklinik für Radiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; and Klinik und Poliklinik für Neurologie (G.T.), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Correspondence to Götz Thomalla, MD, Klinik und Poliklinik für Neurologie, Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. E-mail thomalla{at}uke.uni-hamburg.de
Background and Purpose— Information on safety and efficacy of intravenous thrombolysis with tissue plasminogen activator (tPA) (IV-tPA) in very old acute ischemic stroke (AIS) patients is scarce. We studied outcome and severe hemorrhagic complications in patients aged 80 and older.
Methods— We analyzed data of AIS patients, treated with IV-tPA, in 3 German stroke centers. Neurologic deficit on admission was assessed using the National Institutes of Health Stroke Scale (NIHSS). Outcome was assessed after 90 days using the Modified Rankin Scale (MRS), and favorable outcome was defined as a MRS score of 0 to 1. Severe intracerebral bleeding complications were assessed on follow-up magnetic resonance imaging or cranial computed tomography. Data were compared between patients <80 years of age and patients aged 
80 years.
Results— A total of 228 patients were treated with IV-tPA; 38 (16%) were 80 years or older. There was no difference in NIHSS on admission or onset to treatment time between younger and older patients. Less patients 80 years of age achieved a favorable outcome (26.3 versus 46.8%, P=0.021), and mortality was higher in older patients (21.1 versus 5.3%, P=0.004). There was no difference in the rate of parenchymal hemorrhage (6.3%<80 years versus 5.3%80 years, P=1.000) and symptomatic intracerebral hemorrhage (2.6%<80 years versus 2.6%80 years, P=1.000) between both groups.
Conclusion— There is no increase in severe intracerebral hemorrhage after IV-tPA in very old patients, but outcome is worse as compared with younger patients. There is no evidence to exclude ischemic stroke patients from thrombolysis based on a predefined age threshold.
Key Words: stroke • thrombolytic therapy • treatment outcome
This article has been cited by other articles:
 |
|
 |
|
  E. Meseguer, J. Labreuche, J. M. Olivot, H. Abboud, P. C. Lavallee, O. Simon, L. Cabrejo, A. Echeverria, I. F. Klein, M. Mazighi, et al. Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review Age Ageing, January 1, 2008; 37(1): 107 - 111. [Full Text] [PDF]
|
|
|
|
|
|
M. Uyttenboogaart, E. M. C. Schrijvers, P. C. Vroomen, J. De Keyser, and G.-J. Luijckx Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience Age Ageing, September 1, 2007; 36(5): 577 - 579. [Full Text] [PDF]
|
|
|
|
 |
|
 P A Ringleb, C. Schwark, M Kohrmann, S Kulkens, E Juttler, W Hacke, and P D Schellinger Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 690 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kobayashi, M. Skowronska, T. Litwin, and A. Czlonkowska Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated Emerg. Med. J., February 1, 2007; 24(2): 96 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aleu, P. Mellado, C. Lichy, M. Kohrmann, and P. D. Schellinger Hemorrhagic Complications After Off-Label Thrombolysis for Ischemic Stroke Stroke, February 1, 2007; 38(2): 417 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Khatri, L. R. Wechsler, and J. P. Broderick Intracranial Hemorrhage Associated With Revascularization Therapies Stroke, February 1, 2007; 38(2): 431 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Engelter, L. H. Bonati, and P. A. Lyrer Intravenous thrombolysis in stroke patients of >=80 versus <80 years of age--a systematic review across cohort studies. Age Ageing, November 1, 2006; 35(6): 572 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Neumann-Haefelin, S. Hoelig, J. Berkefeld, J. Fiehler, A. Gass, M. Humpich, A. Kastrup, T. Kucinski, O. Lecei, D. S. Liebeskind, et al. Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke Stroke, October 1, 2006; 37(10): 2463 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P N Sylaja, R. Cote, A. M Buchan, M. D Hill, and on behalf of Canadian Alteplase for Stroke Effecti Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study J. Neurol. Neurosurg. Psychiatry, July 1, 2006; 77(7): 826 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P C A J Vroomen, M Uyttenbogaart, G J Luijckv, A Shuaib, and M Muratoglu Misleading conclusions on rt-PA treatment in the very elderly * Authors' reply. J. Neurol. Neurosurg. Psychiatry, June 1, 2006; 77(6): 799 - 799. [Full Text] [PDF]
|
|
|
|
|
|
M. T. McCormick, K. W. Muir, G. Thomalla, J. Rother, and J. Berrouschot Referral Bias May Underestimate Number of Very Elderly Patients Eligible for rtPA Stroke, April 1, 2006; 37(4): 942 - 943. [Full Text] [PDF]
|
|